Baker Ellis Asset Management’s Amgen AMGN Stock Holding History

Baker Ellis Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-810	Closed	-$202K	–	196
2021 Q1	$202K	Sell	810 -200	-20%	-$47.7K	0.04%	179
2020 Q4	$232K	Buy	+1,010	New	+$233K	0.06%	161
2020 Q3	–	Sell	-714	Closed	-$168K	–	167
2020 Q2	$168K	Buy	+714	New	+$163K	0.05%	161
2017 Q4	–	Sell	-577	Closed	-$108K	–	243
2017 Q3	$108K	Buy	+577	New	+$102K	0.03%	229
2016 Q4	–	Sell	-612	Closed	-$102K	–	241
2016 Q3	$102K	Sell	612 -635	-51%	-$107K	0.03%	237
2016 Q2	$190K	Hold	1,247	–	–	0.06%	191
2016 Q1	$187K	Sell	1,247 -169	-12%	-$25.1K	0.06%	193
2015 Q4	$230K	Buy	1,416 +69	+5%	+$10.8K	0.08%	175
2015 Q3	$186K	Hold	1,347	–	–	0.07%	199
2015 Q2	$207K	Hold	1,347	–	–	0.07%	190
2015 Q1	$215K	Hold	1,347	–	–	0.07%	186
2014 Q4	$215K	Buy	1,347 +60	+5%	+$9.35K	0.07%	181
2014 Q3	$181K	Hold	1,287	–	–	0.06%	200
2014 Q2	$152K	Buy	1,287 +87	+7%	+$10.1K	0.05%	227
2014 Q1	$148K	Hold	1,200	–	–	0.05%	231
2013 Q4	$137K	Hold	1,200	–	–	0.05%	232
2013 Q3	$134K	Hold	1,200	–	–	0.05%	222
2013 Q2	$118K	Buy	+1,200	New	+$125K	0.05%	234

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Baker Ellis Asset Management's AMGN Position: Q2 2021 in Review

Baker Ellis Asset Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 810 shares — an estimated $202K sold.

Baker Ellis Asset Management first reported a position in AMGN in Q2 2013 and held it in 18 quarters. The position peaked at $232K in Q4 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

Baker Ellis Asset Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
Baker Ellis Asset Management sold 810 Amgen shares in Q2 2021, an estimated $202K.
Baker Ellis Asset Management first reported a position in Amgen in Q2 2013 and held it in 18 quarters.
Baker Ellis Asset Management's Amgen position peaked at $232K in Q4 2020.
2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Baker Ellis Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.